M&A Activity
Organigram – Sanity Group Deal: What Changed and What it Means for Germany
This article was originally published in February 2026, and was most recently updated on September 22, 2026.
British American Tobacco
16stories
20 Septlast updated
More in British American Tobacco
- Markets & Stocks
Argent BioPharma Sees 74% Sales Decline, Cantourage Enjoys 62% Sales Increase, & Organigram Progresses With BAT Investment
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June 30, 2024, revealing a sharp drop in revenues but a reigning in of net losses compared to the previous year.
- Markets & Stocks
Jazz Fails Phase 3 Trial in Japan, BAT Set to See Growth From Cannabis Investment, & DanCann Pharma Reports First Profit
Jazz Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”JAZZ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] The pharmaceutical giant announced last week that its flagship cannabinoid treatment, Epidyolex, failed to pass its Phase 3 clinical trial in Japan.
- Uncategorized
Organigram Announces ‘Transformative’ C$124m Investment From Tobacco Giant BAT
Canadian cannabis producer Organigram has announced a further major investment from tobacco giant British American Tobacco (BAT).
- Markets & Stocks
Cantourage Sees Revenues ‘Almost Triple’, BAT Invests $10m In New CBD Joint Venture, & Love Hemp’s New Owner Targets IPO
Cantourage [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”HIGH.F” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] German-based medical cannabis operator Cantourage has seen its stock jump 22% this week after revealing a 95% increase in revenues in its preliminary Q1 results.
- Adult-Use
Cantourage’s €80m Listing Sees Its Share Price Skyrocket 300%
CANTOURAGE has become the third and largest major European medical cannabis operator to go public this year, as investment confidence in the cannabis sector shows further signs of recovery.
- Adult-Use
Sanity Group’s Record Funding Round Led By BAT Could Bring More Big-Tobacco Capital To Cannabis, But Concerns Remain Over Conflicts Of Interest
LAST week Berlin-based cannabis operator Sanity Group closed Europe’s largest ever cannabis investment round worth €37.6m, bringing its total funding to date to over €100m.
- Press releases
Kanvas Receives Strategic Investment from Btomorrow Ventures, A Division Of BAT, As Lead Investor
THE Kanvas Co. (“Kanvas”), developer of patented electronic vaporizer technology solutions designed to deliver device safety, performance, and reliability for nicotine, cannabis, and cannabidiol (CBD) delivery systems, today announced the completion of a strategic investment (the ”Investment”).
- CBD Market
No longer up-in-smoke (only)
Earlier in the year, British American Tobacco (BAT), announced that they secured a nearly 20 percent interest in Canadian cannabis producer Organigram.
